Virginia National Bank Abbott Laboratories Transaction History

Virginia National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $155,039 - $226,710	-2,468 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $818 - $887	-10 Reduced 0.4%	2,468 $206,000
Q2 2019 Jul 08, 2019	BUY	$72.88 - $85.0 $180,596 - $210,630	2,478 New	2,478 $208,000
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $265,012 - $320,400	-4,002 Closed	0 $0
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $3,278 - $3,713	-50 Reduced 1.23%	4,002 $289,000
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $246,402 - $297,254	4,052 New	4,052 $297,000

3,196

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Virginia National Bank, based on Form 13F filings with the SEC.

Stay updated on Virginia National Bank with notifications on news.